This model has been built to visualize quantitative market trends within the Diabetes Care Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Insulin Pumps and Continuous Glucose Monitors market for the year 2020 and beyond. People with insulin-dependent diabetes require intensive insulin therapy to manage their blood glucose levels within a healthy range.
Insulin can be delivered by syringes and vials, insulin pumps, and insulin pens. Insulin Pumps include Traditional Insulin Pumps & Accessories and Patch Pumps. Continuous glucose monitoring system is used for the continuous measurement of blood glucose. The system includes an implantable sensor with wireless transmission capability and a monitor.
This model has been built to visualize quantitative market trends within the Diabetes Care Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Insulin Pumps and Continuous Glucose Monitors market for the year 2020 and beyond. People with insulin-dependent diabetes require intensive insulin therapy to manage their blood glucose levels within a healthy range.
Insulin can be delivered by syringes and vials, insulin pumps, and insulin pens. Insulin Pumps include Traditional Insulin Pumps & Accessories and Patch Pumps. Continuous glucose monitoring system is used for the continuous measurement of blood glucose. The system includes an implantable sensor with wireless transmission capability and a monitor.
Global Wearable Injectors (On & Off Body) Market to 2026
News provided by
Share this article
ResearchAndMarkets.com s offering.
The global wearable injectors market is expected to grow at a CAGR of around 12.0% during 2020-2026.
Wearable injectors are drug delivery devices created for single-use wearable device technologies, designed to deliver large volume drugs to the patients over long durations. Pharmaceutical and biotechnology companies are witnessing a growing trend of a diversion of their investments towards the development of routes of administration of biologics and other drugs particularly for subcutaneous self-administration by patient populations.
The global wearable injectors market report elucidates key industry trends, industry dynamics along with the quantitative analysis of the report. The report presents a clear picture of the global wearable injectors market by segmenting the market based on type, technology, therapy, end user and region. We believe that t
Share:
New York, Dec. 24, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Automated Insulin Delivery System Market Research Report by Disease Type, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p05913312/?utm source=GNW
The Global Automated Insulin Delivery System Market is expected to grow from USD 576.09 Million in 2019 to USD 952.86 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.74%.
Market Segmentation & Coverage:
This research report categorizes the Automated Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
| Press Release
Automated Insulin Delivery System Market Research Report by Disease Type, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19
New York, Dec. 24, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Automated Insulin Delivery System Market Research Report by Disease Type, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p05913312/?utm source=GNW
The Global Automated Insulin Delivery System Market is expected to grow from USD 576.09 Million in 2019 to USD 952.86 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.74%.
Market Segmentation & Coverage: